Download PDFPDF

Trachoma: global magnitude of a preventable cause of blindness
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Estimation for trachoma prevalence in Egypt

    We read with great interest the article by Mariotti et al. estimating the global prevalence of trachoma. For the country of Egypt, the article refers only to the published survey in Menofiya Governorate in the Nile Delta, suggesting that only this single governorate is endemic for trachoma. This is far from the case, however, as two other studies shed light on trachoma in other areas of Egypt. Both studies were presen...

    Show More
    Conflict of Interest:
    None declared.